Veratryl alcohol → N-[1-{[3,4-Bis(methyloxy)phenyl]methyl}-4-(methyloxy)-1H-indazol-3-yl]-5-chloro-2-thiophenesulfonamide
Reaction equation
ClC1SC(S([N:10]([S:22]([C:25]2[S:26][C:27]([Cl:30])=[CH:28][CH:29]=2)(=[O:24])=[O:23])[C:11]2[C:19]3[C:14](=[CH:15][CH:16]=[CH:17][C:18]=3[O:20][CH3:21])[NH:13][N:12]=2)(=O)=O)=CC=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[CH3:50][O:51][C:52]1[CH:53]=[C:54]([CH2:60]O)[CH:55]=[CH:56][C:57]=1[O:58][CH3:59].N(C(OC(C)C)=O)=NC(OC(C)C)=O.[OH-].[Na+]>C1COCC1.O.C(Cl)Cl>[CH3:50][O:51][C:52]1[CH:53]=[C:54]([CH2:60][N:13]2[C:14]3[C:19](=[C:18]([O:20][CH3:21])[CH:17]=[CH:16][CH:15]=3)[C:11]([NH:10][S:22]([C:25]3[S:26][C:27]([Cl:30])=[CH:28][CH:29]=3)(=[O:24])=[O:23])=[N:12]2)[CH:55]=[CH:56][C:57]=1[O:58][CH3:59]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 60 °C
Procedure
To a solution of 5-chloro-N-[(5-chloro-2-thienyl)sulfonyl]-N-[4-(methyloxy)-1H-indazol-3-yl]-2-thiophenesulfonamide (for a preparation see Intermediate 10) (150 mg, 0.286 mmol), triphenylphosphine (150 mg, 0.572 mmol) and [3,4-bis(methyloxy)phenyl]methanol (Aldrich) (96 mg, 0.57 mmol) in THF (3 mL) was added at room temperature di-iso-propyl azodicarboxylate (0.113 mL, 0.572 mmol). The resulting mixture was stirred at 60° C. for 3 hours. DCM (3 mL) and water (3 mL) were added and the organic phase was separated. The aqueous layer was further extracted with 3 mL of DCM. The combine organic solutions were dried over an hydrophobic frit and concentrated under a nitrogen stream in a blowdown unit. The residue was purified by chromatography on silica 50 g cartridge on Flashmaster II using a gradient of 0-100% EtOAc in DCM over 60 min. The appropriate fractions were combined and evaporated in vacuo and the residue was dissolved in methanol (5 mL) and treated with a solution of sodium hydroxide (2M, 1.43 mL, 2.86 mmol). The resulting mixture was stirred at 60° C. for 2 hours. The solvents were evaporated off under reduced pressure, and the residue was partitioned between 2 mL of DCM, 3 mL of water. A solution of dilute HCl solution was added until the pH of the aqueous layer was around 1. The organic phase was separated and the aqueous layer was further extracted with 2 mL of DCM. The combined organic solutions were dried over an hydrophobic frit and concentrated under a stream of nitrogen in a blowdown unit. The residue was dissolved in 1:1 MeOH-DMSO (1 mL) and purified by MDAP (supelcosil ABZ+Plus column) eluting with solvents A/B (A: Water+0.1% Formic acid, B: MeCN:Water 95:5+0.05% Formic acid). The solvent was removed from appropriate fractions under a stream of nitrogen in the Radleys blowdown apparatus to give the title compound (52.6 mg, 37%). LCMS (System A) RT=1.17 min, ES+ve m/z 494/496 (M+H)+.
Workup
- customthe organic phase was separated
- extractionThe aqueous layer was further extracted with 3 mL of DCM
- customThe combine organic solutions were dried over an hydrophobic frit
- concentrationconcentrated under a nitrogen stream in a blowdown unit
- customThe residue was purified by chromatography on silica 50 g cartridge on Flashmaster II
- customover 60 min
- customevaporated in vacuo
- dissolutionthe residue was dissolved in methanol (5 mL)
- stirringThe resulting mixture was stirred at 60° C. for 2 hours
- customThe solvents were evaporated off under reduced pressure
- customthe residue was partitioned between 2 mL of DCM, 3 mL of water
- additionA solution of dilute HCl solution was added until the pH of the aqueous layer
- customThe organic phase was separated
- extractionthe aqueous layer was further extracted with 2 mL of DCM
- customThe combined organic solutions were dried over an hydrophobic frit
- concentrationconcentrated under a stream of nitrogen in a blowdown unit
- dissolutionThe residue was dissolved in 1:1 MeOH-DMSO (1 mL)
- custompurified by MDAP (supelcosil ABZ+Plus column)
- washeluting with solvents A/B (A: Water+0.1% Formic acid, B
- customThe solvent was removed from appropriate fractions under a stream of nitrogen in the Radleys blowdown apparatus
Sources & evidence
- ORD record
- ord-ffe358f527ab4073bd5eb239cb8d8da9
- Source dataset
- uspto-grants-2012_11
- Patent number
- US08304446B2
Reaction notes
Loading…